Literature DB >> 25188822

Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study.

Yoichiro Takayanagi1, Adam P Spira, O Joseph Bienvenu, Rebecca S Hock, Michelle C Carras, William W Eaton, Ramin Mojtabai.   

Abstract

OBJECTIVE: Past studies have shown that many individuals who use antidepressants have no current or lifetime history of mental disorders. However, recent studies suggest that the one-time retrospective evaluation of mental disorders commonly used in such studies may substantially underestimate the true lifetime prevalence of mental disorders. We examined the prevalence of mental disorders, assessed prospectively over multiple interviews, among individuals currently using antidepressants in a community sample.
METHOD: Using data from the Baltimore Epidemiologic Catchment Area (ECA) Study Wave 1 (1981) through Wave 4 (2004-2005) (N = 1,071), we assessed lifetime prevalence of common mood and anxiety disorders according to DSM-III and DSM-III-R criteria, based on 4 interviews, among participants who reported current antidepressant use. Furthermore, we examined factors associated with current antidepressant use.
RESULTS: Thirteen percent of participants at Wave 4 reported currently using antidepressant medications. Among antidepressant users, 69% never met criteria for major depressive disorder (MDD); and 38% never met criteria for MDD, obsessive-compulsive disorder, panic disorder, social phobia, or generalized anxiety disorder in their lifetime. Female gender, Caucasian ethnicity, recent or current physical problems (eg, loss of bladder control, hypertension, and back pain), and recent mental health facility visits were associated with antidepressant use in addition to mental disorders.
CONCLUSIONS: Many individuals who are prescribed and use antidepressant medications may not have met criteria for mental disorders. Our data indicate that antidepressants are commonly used in the absence of clear evidence-based indications. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25188822      PMCID: PMC4504011          DOI: 10.4088/JCP.13m08824

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  31 in total

1.  Datapoints: psychotropic drug prescriptions by medical specialty.

Authors:  Tami L Mark; Katharine R Levit; Jeffrey A Buck
Journal:  Psychiatr Serv       Date:  2009-09       Impact factor: 3.084

2.  Overuse of antidepressants in a nationally representative adult patient population in 2005.

Authors:  Rena Conti; Alisa B Busch; David M Cutler
Journal:  Psychiatr Serv       Date:  2011-07       Impact factor: 3.084

Review 3.  Overuse of antidepressant drugs for the treatment of depression.

Authors:  Jon Jureidini; Anne Tonkin
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Increase in antidepressant medication in the US adult population between 1990 and 2003.

Authors:  Ramin Mojtabai
Journal:  Psychother Psychosom       Date:  2008-01-25       Impact factor: 17.659

5.  National patterns in antidepressant medication treatment.

Authors:  Mark Olfson; Steven C Marcus
Journal:  Arch Gen Psychiatry       Date:  2009-08

6.  Clinical diagnosis of depression in primary care: a meta-analysis.

Authors:  Alex J Mitchell; Amol Vaze; Sanjay Rao
Journal:  Lancet       Date:  2009-07-27       Impact factor: 79.321

7.  National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

8.  Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).

Authors:  Koen Demyttenaere; Anke Bonnewyn; Ronny Bruffaerts; Giovanni De Girolamo; Isabelle Gasquet; Viviane Kovess; Josep Maria Haro; Jordi Alonso
Journal:  J Affect Disord       Date:  2008-03-10       Impact factor: 4.839

9.  Unmet need for treatment of major depression in the United States.

Authors:  Ramin Mojtabai
Journal:  Psychiatr Serv       Date:  2009-03       Impact factor: 3.084

Review 10.  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Authors:  Marc Stone; Thomas Laughren; M Lisa Jones; Mark Levenson; P Chris Holland; Alice Hughes; Tarek A Hammad; Robert Temple; George Rochester
Journal:  BMJ       Date:  2009-08-11
View more
  12 in total

1.  Trends in Central Nervous System-Active Polypharmacy Among Older Adults Seen in Outpatient Care in the United States.

Authors:  Donovan T Maust; Lauren B Gerlach; Anastasia Gibson; Helen C Kales; Frederic C Blow; Mark Olfson
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

2.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Authors:  Donovan T Maust; Frederic C Blow; Ilse R Wiechers; Helen C Kales; Steven C Marcus
Journal:  J Clin Psychiatry       Date:  2017-04       Impact factor: 4.384

3.  The effects of S-adenosyl-L-methionine-vitamin B complex on mild and moderate depressive symptoms.

Authors:  G Djokic; D Korcok; V Djordjevic; A Agic; A Rankovic; Dejanovic Djukic
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

4.  Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.

Authors:  Donovan T Maust; Kenneth M Langa; Frederic C Blow; Helen C Kales
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-18       Impact factor: 3.485

5.  Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats.

Authors:  Abdullah Gul; Alexander Pastuszak; Levent Kabasakal; Jenna Bates; Serdar Altinay; Duygu Sultan Celik; Atilla Semercioz; Ege Can Serefoglu
Journal:  Eurasian J Med       Date:  2019-02

6.  Chronic fatigue syndrome in the emergency department.

Authors:  Christian R Timbol; James N Baraniuk
Journal:  Open Access Emerg Med       Date:  2019-01-11

Review 7.  Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies.

Authors:  Alex J Mitchell; Motahare Yadegarfar; John Gill; Brendon Stubbs
Journal:  BJPsych Open       Date:  2016-03-09

8.  Time Trend in Psychotropic Medication Use in Spain: A Nationwide Population-Based Study.

Authors:  Pilar Carrasco-Garrido; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Jesús Esteban-Hernández; Alejandro Álvaro-Meca; Ana López-de Andrés; José Luis DelBarrio-Fernández; Rodrigo Jiménez-García
Journal:  Int J Environ Res Public Health       Date:  2016-11-24       Impact factor: 3.390

9.  Depression as a modifiable factor to decrease the risk of dementia.

Authors:  O P Almeida; G J Hankey; B B Yeap; J Golledge; L Flicker
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

10.  Utilization of Mental Health Care, Treatment Patterns, and Course of Psychosocial Functioning in Northern German Coronary Artery Disease Patients with Depressive and/or Anxiety Disorders.

Authors:  Anna Lisa Westermair; Anja Schaich; Bastian Willenborg; Christina Willenborg; Stefan Nitsche; Heribert Schunkert; Jeanette Erdmann; Ulrich Schweiger
Journal:  Front Psychiatry       Date:  2018-03-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.